Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Bristol Myers Squibb’s Sotyktu accepted by SMC for plaque psoriasis

More than 133,520 people in Scotland are affected by the inflammatory condition

- PMLiVE

Integrating shared decision-making in patient engagement plans

By Abi Bowden

- PMLiVE

Women’s Health Faces Some Difficult Headwinds. Here’s How We Can Move Forward

When it comes to women’s health, “we are a bit behind — almost where oncology was 20 years ago and neuroscience was about 10 years ago,” says Sandra Milligan, Head...

Medscape Education

- PMLiVE

Bristol Myers Squibb gains rights to SystImmune’s ADC candidate for up to $8.4bn

BL-B01D1 has shown promise against a range of solid tumours including lung cancer

- PMLiVE

Almirall and etherna partner to develop mRNA-based therapies for severe skin diseases

Dermatological diseases are estimated to affect 1.8 billion people worldwide

- PMLiVE

FDA grants fast track designation to Candel’s immunotherapy in pancreatic cancer

The disease is the fourth leading cause of cancer-related death in the US, accounting for 3.3% of new cancer cases

- PMLiVE

Reimagining scientific publications

By Sam Kew

Hear from her: A Passionate Cause: Elevating Women to Reshape Medicine

Medscape Education

Hear from her: Women’s Health Faces Some Difficult Headwinds. Here’s How We Can Move Forward

Wilmington Healthcare

Hear from her: A “Leaky Pipeline” and the Loss of Talented Female Physicians

Medscape Education

Hear from Her: Planting the Seeds for Future Women Leaders in Medicine

Medscape Education

- PMLiVE

BOLDSCIENCE launches BOLDAPPROVALS division

BOLDAPPROVALS, a new division of the medical communications agency BOLDSCIENCE, will help pharmaceutical and biotech clients gain regulatory approval with comprehensive services that include preparation for US Food and Drug...

BOLDSCIENCE

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links